Cystine depleted cystinotic fibroblasts incubated in cystine-free medium accumulate lysosomal-free cystine from the degradation of cystine-containing intracellular and extracellular proteins. In this report we have used this characteristic of these cells to study lysosomal proteolysis. We find that inhibitors of protein synthesis (cycloheximide, emetine, and puromycin) inhibit cystine accumulation from endogenous proteins and therefore act to inhibit lysosomal proteolysis of these proteins. However, cycloheximide does not inhibit cystine accumulation derived from the degradation of the extracellular disulfide-rich proteins, albumin and RNase, but lysosomal cystine accumulation derived from insulin is inhibited by cycloheximide. We conclude that a rapidly turning over protein may be required for the lysosomal degradation of intracellular and some extracellular proteins.
Introduction
The mechanisms that regulate proteolysis of endogenous and exogenous proteins remain poorly understood. Significant advances in the understanding of the degradation of endogenous proteins have occurred with the delineation of a nonlysosomal cytoplasmic system that has a neutral pH optimum and requires ATP (1) , and in the discovery of ubiquitin, which is a 76-residue protein conjugated to short-lived proteins destined for nonlysosomal proteolysis under nutritionally complete conditions (2) . Extracellular proteins that enter the cell by pinocytosis are degraded in lysosomes, as is also the case for some long-lived cellular proteins, and for proteins degraded during "step-down" conditions (2) . The mechanism that targets intracellular proteins for lysosomal degradation under conditions of nutritional deprivation is not known, however, regulatory systems that balance protein synthesis and protein degradation appear to be required to maintain homeostasis throughout the cell cycle.
We present data showing that protein synthesis is required for the lysosomal degradation of endogenous proteins in human fibroblasts incubated under conditions of nutritional deprivation. This has been accomplished by using cells derived from patients with the autosomal recessive condition cystinosis, An abstract of this work appeared in Pediatr. Res. 1984 whose lysosomes retain cystine from the degradation of cystinecontaining proteins (3) (4) (5) . When such cells are incubated in cystine-free medium, lysosomal cystine only accumulates from the degradation of cystine-containing proteins (3) . Lysosomal cystine accumulation is thus a direct measure of lysosomal proteolysis under these conditions. We find that although inhibitors of protein synthesis inhibit the lysosomal degradation of endogenous cystine-containing proteins, they do not inhibit the degradation of extracellular proteins taken up by pinocytosis. In the case of one receptor-mediated protein, insulin, lysosomal degradation is also inhibited. These results are consistent with the requirement for a short half-lived protein to participate in lysosomal degradation of endogenous proteins. We speculate that this or a similar protein may also be required for lysosomal degradation of insulin after dissociation from its receptor.
Methods
Diploid epithelial fibroblast cultures were derived from skin biopsies of patients with nephropathic cystinosis and maintained in a modified Ham's F12 medium supplemented with 10% (vol/vol) fetal-bovine serum and incubated at 37°C in a humidified incubator flushed with an air/CO2 (19:1) mixture. Control normal fibroblasts were purchased from the Human Genetic Mutant Cell Repository. Cystine-free medium was the same medium with cystine deleted. Cells were harvested by trypsin treatment and immediately broken by ultrasonic disruption in the presence of 5 mM N-ethylmaleimide in 100 MM phosphate buffer pH 7.4. Cell proteins were precipitated by the addition of one-fourth volume 12% sulphosalicylic acid and removed by centrifugation. The supernatant was analyzed for free [35S]cystine by one-dimensional high voltage electrophoresis on paper (6), or for total free-cystine by a cystine-binding protein assay (7) . Cell number was determined by a Coulter counter (Coulter Instruments, Inc., Hialeah, FL), model ZF, and cell protein by Lowry's method (8) . Soluble radioactivity in cell supernatant or medium was determined by counting an aliquot in Aquasol (New England Nuclear, Boston, MA) in a Beckman LS-100 liquid scintillation counter (Beckman Instruments, Inc., Fullerton, CA). Radioactivity in protein was determined the same way after dissolving the pellet in 100 to 300 ul of 0.1 N NaOH. Percent acid soluble radioactivity was determined by dividing the sum of the acid soluble radioactivity present in cells and medium by the total radioactivity present in the system. For cystine accumulation experiments, the cell protein pool was labeled by addition of L-[35S]cystine (-500 Ci/mMol, New England Nuclear) to complete medium containing 133 MM unlabeled cystine on dishes of confluent fibroblasts for periods as described in Results. Counting efficiency for [35Sjcystine was 94%. Cystine-depleted cystinotic fibroblasts were prepared by incubation for 30 min in cystine-free medium containing I mM cysteamine (6) . Polyacrylamide gel electrophoresis was performed by the method of Laemmli (9) using a 4% stacking gel and a 10% analytical gel in the presence of 0.1% sodium dodecyl sulfate. Autoradiography was accomplished by exposure of the dried gel to x-ray film at -70°C for 4 d.
The effect of protein synthesis inhibitors on proteolytic activity of cystinotic fibroblast sonicates was determined using a previously described assay for cathepsin D (10). Sigma (Sigma Chemical Co., St. Louis, MO) bovine hemoglobin type II in citrate buffer at pH 3.0 was added to tubes containing aliquots of cell sonicates in a total volume of 0.8 ml in the presence or absence of the inhibitors, and the mixture was incubated at 370C for 10 min, whereupon 0.5 ml of chilled 0.6 M trichloroacetic acid was added and the tubes placed on ice for an additional 10 min. The tubes were then spun in a Beckman microfuge and the optical density of the supernatant measured at 280 nm.
'251-insulin dissociation experiments were performed as previously described (11) by suspending cystinotic fibroblasts in Hepes binding buffer (0.1 M Hepes, 0.12 M NaCl, 1.2 mM MgSO4, 2.5 mM KCI, 10 mM glucose, 1 mM EDTA, and 10 mg/ml bovine serum albumin
[BSA]) containing 0.3 ng/ml '25I-insulin (6.0 X 104 cpm/ml, 90 MCi! Mg) at 150C for 3 h, then centrifuging and resuspending at a 1 to 20 dilution in unlabeled binding buffer with or without the addition of 100 MM cycloheximide. At the indicated points the tubes were centrifuged and cell associated radioactivity determined with a Tracor gamma counter (TM Analytic, Elk Grove Village, IL). '25I-insulin binding was determined by incubation of a cystinotic fibroblast suspension in 0.6 ml binding buffer containing 0.2-0.4 ng/ml '25I-insulin (4 X I04 cpm/ml) with and without the addition of 100 MM cycloheximide. Binding was allowed to proceed at 15°C and at the indicated times, 200-Mgl aliquots of the suspension were removed and centrifuged, the supernatant removed, and cell associated radioactivity in the cell pellet determined as described (12) . Nonspecific binding was measured by adding excess unlabeled insulin (100 Mg/ml) to parallel tubes and treating as above. The effect of cycloheximide on insulin receptors at the cell surface was determined by preincubating plates of cystinotic fibroblasts for 24 h at 37°C in complete medium containing 100 4M cycloheximide, washing the plates four times with phosphate-buffered saline (PBS), adding binding buffer containing '25I-insulin (0.5 ng/ml, 8 X 104 cpm/ml) and allowing binding to occur at 15°C. Nonspecific binding was measured in parallel plates that also contained 100 Mg/ml of unlabeled insulin. After a 5-h incubation the cells were washed four times in PBS and the cell monolayer dissolved in 1.0 ml of 0.1 N NaOH for gamma counting. Specific binding was calculated as counts per minute per milligram of cell protein minus the cell associated radioactivity recovered in the presence of excess unlabeled insulin. Reagents were purchased from Sigma, Calbiochem-Behring, Div. of American Cyanamid, La Jolla, CA, New England Nuclear, or Eli Lilly, Indianapolis, IN (insulin), and were the best available grade. Statistical analyses were performed by paired t test.
Results
Endogenous proteins. (6) , placed in unlabeled cystine-free medium containing 10% (vol/vol) fetal bovine serum with or without the addition of 100 MM cycloheximide, and harvested after an additional 24 h incubation. Cells and media were then analyzed as described in Methods. Cycloheximide significantly (P < 0.01 to P < 0.10) inhibited lysosomal [35S]cystine accumulation by 71% after a 48-h label, to 77% after a 4-h label. There was a significant (P < 0.05 to P < 0.10) increase in the amount of acid soluble radioactivity present after the 24-h incubation. However, the amount of [35Sjcystine present in the protein (acid precipitable) fraction treated with cycloheximide was not significantly different from controls for any duration of label.
In Fig. 1 (Table II) . Inhibition also occurred at 4 h of incubation after either a 4-or 24-h prelabel. However, due to the slow rate of cystine accumulation, statistical significance is not achieved between control and treated cells during this interval. Not shown in Table II is the effect of these agents on the amount of residual label in the protein pool or in the generation of acid soluble radioactivity. The same effect was seen as in the cycloheximide-treated cells: the amount of acid soluble radioactivity was increased after both the 4-h prelabel (29% increase for puromycin), and 24-h prelabel (24% increase for emetine, 20% increase for puromycin). No consistent effect was seen on the amount of radioactivity remaining in the protein pool as was also found in the cycloheximide-treated cells.
The cytoplasmic protease inhibitors L-l-tosylamido-2-phenylethyl-chloromethyl ketone (TPCK)1 and N-a-p-tosyl-Llysine-chloromethyl ketone (TLCK) (1) and bestatin (2) were studied to determine if the labeled cystine accumulation derived from proteins labeled for only 4 TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone. Exogenous proteins. The effect of cycloheximide on lysosomal cystine accumulation derived from the degradation of extracellular cystine-containing proteins is shown in Table III . We have previously shown that intralysosomal free-cystine accumulation in cystinotic fibroblasts incubated in cystine-free medium occurs from the degradation of cystine-containing proteins added to the culture medium (3, 4) . The data in Table III show that cystine accumulation from BSA and RNase was not significantly inhibited by cycloheximide, but cystine accumulation from insulin was (P < 0.01). In another experiment of the type shown in Table III , cystine-depleted cystinotic fibroblasts were incubated in medium containing 1 mg/ml insulin with or without the addition of 10 AM cycloheximide. Attempts to replicate these experiments using emetine and puromycin were unsuccessful due to cellular detachment and disintegration that occurred when these agents were added to the medium in addition to the extracellular cystine-rich protein. This toxicity is not seen when these proteins are added alone, and cytotoxicity in the absence of these proteins was only seen in the case of emetine (see legend to Table II) .
No apparent effect of cycloheximide on insulin binding or release from the plasma membrane receptor was seen in these experiments (see Fig. 2 A and B) when binding of insulin to the plasma membrane was examined at intervals of 0-5 h.
Preincubation of cystinotic cells for 24 h with 10 MM cycloheximide also had no effect on binding of '251-insulin to these cells: control cells bound 456±82.3 cpm/mg '251I-insulin, 100 MM cycloheximide pretreated cells bound 520±165 cpm/mg '25I-insulin (P > 0.5) and 10 AM cycloheximide pretreated cells bound 520.6±363 cpm/mg 1251I-insulin (P > 0.5). Points are the mean of triplicate plates.
Comparison to normal fibroblasts. Cystinotic fibroblasts appear metabolically normal with the exception of the inability to transport cystine from lysosomes, which results from a defective lysosomal transport system for cystine (13, 14) . This defect is specific for cystine; no other aminoacid, including Fig.  4 , in which the protein pellets obtained from cells harvested in an experiment like that in Fig. 1 were analyzed by SDS-PAGE followed by autoradiography. radation of glucocorticoid-induced tyrosine amino-transferase at low pH (6.5) in hepatoma cells was completely inhibited by 100 MM cycloheximide. Baccino et al. (20) found that cycloheximide inhibited starvation-enhanced proteolysis in perfused rat livers, and suggested that it acted through suppression of the autophagic process, as well as by decreasing the lysosomal protease system. Ballard found that cycloheximide inhibited protein breakdown in a human breast carcinoma line (T47D) under all conditions, but inhibited breakdown in a rat myoblast line only under control conditions, and increased breakdown of protein if serum were present (21) . The effects were also attributed to interference with lysosomal proteolysis. At the end of the labeling period they were washed three times in phosphate-buffered saline, replaced in unlabeled medium, and plates harvested at 0, 4, and 24 h of incubation. 50-Mgg aliquots of the labeled cell proteins were then analyzed by SDS-PAGE and autoradiography as described in Table I show that cycloheximide inhibits the degradation of endogenous proteins regardless of labeling period. Lysosomal cystine accumulated from the 4-h-labeled pool, as well as from the 24-and 48-h pool (Tables I and II) even after only 4 h of incubation (Table II) . This is consistent with the step-down (cystine-free medium) conditions used in these experiments in which lysosomal degradation of endogenous proteins would be expected. This finding is reinforced by the lack of effect of the cytoplasmic protease inhibitors TPCK and TLCK, and bestatin, on lysosomal-cystine accumulation after the protein pool had been labeled for only 4 h. If degradation were cytosolic, followed by entry of label into the lysosome, bestatin and TPCK and TLCK should have inhibited the observed cystine accumulation: no such inhibition was observed.
The increase in the amount of acid soluble radioactivity produced by the cells in the presence of cycloheximide (Table  I) suggests that total proteolysis is not inhibited, but shifted to a nonlysosomal site. The magnitude of this shift cannot be quantified from these data, however, because cycloheximide also inhibits resynthesis of labeled cystine back into the protein pool. For the same reason, whether total cell proteolysis is increased or unchanged under these conditions cannot be determined.
The concentration of cycloheximide required to inhibit maximally the incorporation of [35S~cyst(e)ine into protein and to inhibit lysosomal degradation of labeled endogenous proteins is the same. 50 MAM cycloheximide almost completely abolishes protein synthesis and reduces lysosomal [3'S]cystine accumulation by -65% (Fig. 1) . Protein synthesis was also inhibited by >97% by 100 AM concentrations of puromycin and emetine.
This concentration ofthese compounds also inhibited lysosomal cystine accumulation from the 24-h labeled protein pool by 48-72% (Table II) . These data strongly support the hypothesis that protein synthesis is required for the lysosomal degradation of endogenous proteins under step-down conditions regardless of protein half-life, since no inhibitory effect of cycloheximide, emetine, or puromycin on the degradation of hemoglobin by cell sonicates could be demonstrated (see Results).
Extracellular proteins gain access to the interior of the cell either by pinocytosis or receptor-mediated endocytosis. Proteins taken up by pinocytosis may remain in the fluid phase or be adsorbed onto the plasma membrane (22) . Although adsorptive pinocytosis may enhance the rate of entry of a protein into the cell, it does not alter its destination, which is into the lysosomal system via fusion of pinosomes with primary (hydrolase-containing) lysosomes. Albumin and RNase lack specific cell surface receptors and presumably enter the cell via pinocytosis. We have previously shown that addition of such cystine-rich proteins to cultures of cystine-depleted cystinotic fibroblasts produces an increased cystine accumulation that results from the lysosomal degradation of these proteins with retention of the cystine moieties (3). Addition of cycloheximide under these conditions does not impede lysosomal cystine accumulation (Table III) , consistent with the constituitive nature of proteolysis within the lysosomal system. Table III also shows that cycloheximide does not interfere with the ability of cystinotic fibroblasts to accumulate cystine since cystine accumulation from BSA and RNase was unimpaired in the presence of 100 MM concentration of this agent.
Insulin binds to a cell surface receptor and is internalyzed. Insulin taken up in this manner is degraded lysosomally, whereas the fate of the receptor is uncertain. Recent evidence suggests a dissociation of insulin from its receptor before entry into lysosomes (18) . Prior work in a fibroblastic cell line has demonstrated that cycloheximide at concentrations of 1 to 17.5 uM causes an accumulation of insulin receptors at the cell surface (23) . These cells are different from normal fibroblasts, however in that they contain a large intracellular receptor pool. Other studies using normal fibroblasts found that cycloheximide lengthens receptor half-life by blocking receptor inactivation, but has no effect on receptor internalization (24). In the current study we found that 100 MM cycloheximide had no direct effect on insulin binding to or dissociation from the plasma membrane of cystinotic fibroblasts ( Fig. 2 A and B) , and that pretreatment of cystinotic cells for 24 h with either 10 or 100 gM cycloheximide had no effect on insulin binding to the cell surface (see Results). However, cycloheximide in concentrations of 10 or 100 MM inhibits the amount of lysosomal cystine that accumulates from the addition of insulin to these cells. The interpretation of this experiment is difficult, because to produce measurable cystine accumulation a large concentration of insulin is required (0.1 to 1.0 mg/ml) that is much greater than that required to saturate all cell surface insulin receptors. Our data are consistent with that of Knutson et al. (24) that cycloheximide interferes with insulin degradation at a step distal to receptor internalization. Since insulin is presumably entering the cell both by pinocytosis and receptor-mediated endocytosis, it is possible that cycloheximide inhibits only the receptor mediated pathways but does not inhibit fluid-phase pinocytosis, consistent with the lack of effect on cystine accumulation derived from BSA and RNase.
Ciechanover et al. have defined ubiqitin as a necessary element for the nonlysosomal degradation of short-lived intracellular proteins under normal conditions (2) . Their studies using a temperature-sensitive cell cycle mutant (ts 85) indicate that this ATP-dependent-ubiquitin system accounts for the bulk of selective protein degradation under these conditions (25, 26) . Inhibition of synthesis of a similar protein could account for the interference with lysosomal proteolysis produced by the protein synthesis inhibitors described in the current report. It is possible that the lysosomal degradation of receptormediated proteins also shares this pathway since insulin degradation is also inhibited by these agents. Further work is required to identify the putative protein involved and its role in lysosomal degradation of intracellular proteins.
